article thumbnail

CBD treatment improved nonseizure outcomes, reduced seizure burden in epilepsy

Medical Marijuana Program Connection

January 05, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on. “ data-action=”subscribe”> Subscribe We were unable to process.

article thumbnail

MAPS Is Pushing For FDA Approval Of MDMA-Assisted Therapy

Veriheal

Colorado recently passed legislation allowing for “healing centers” utilizing shrooms to start opening as soon as 2024, and Oregon is trending in a similar direction. As psilocybin therapy also becomes a popular topic of discussion, some researchers have studied using MDMA and mushrooms together for mental health treatment.

Therapy 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

WA’s Cannabis Employment Protections, Psilocybin-Color Blindness Case Study, & Ketamine’s Rise Explained

Veriheal

Even so, the NI says the self-study, along with various other reports, is enough to conclude that this topic deserves further research. Make sure you check in with a medical professional before pursuing any ketamine treatments. This means workplaces will essentially treat cannabis use the same way they treat alcohol consumption.

article thumbnail

12 Things You Missed at CannMed 23

Medicinal Genomics

The production company for High Science , a major cable channel documentary, once again shot the entire CannMed 23 summit in preparation for the summit’s inclusion in its first season scheduled for release later this year or early in 2024. Stay tuned for that.

article thumbnail

Green Light Law Group: Oregon Psilocybin Update: Advisory Board Subcommittees Begin Finalizing Rule Recommendations

Cannabis Law Report

The Oregon Psilocybin Advisory Board (Advisory Board) held a meeting on October 27 to begin fine tuning recommendations for the first regulated psilocybin treatment model in the United States. OHA will conduct rulemaking on those topics in September 2022 and rules will go into effect on December 30, 2022. By Brett Mulligan.

Law 52
article thumbnail

The Week in Weed: October 25, 2019

The Blunt Truth

The 2019 edition of the Hemp and CBD Industry Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that number could hit $10 billion by 2024. Tourette syndrome and intractable neuropathic pain are now eligible for treatment with medical cannabis.

Hemp 58
article thumbnail

Green Light Law Group: Oregon Psilocybin Advisory Board Approves Training and Products Recommendations

Cannabis Law Report

Below is a breakdown of the topics core training covers and the minimum hours students would devote to each subject: Historical, Traditional, and Contemporary Plant Medicine Practices and Applications (12 Hours). Group Psilocybin Facilitation (8 Hours).

Law 52